Advances in the application of immunoadsorption in autoimmune encephalitis / 中华神经科杂志
Chinese Journal of Neurology
; (12): 764-769, 2022.
Article
em Zh
| WPRIM
| ID: wpr-957966
Biblioteca responsável:
WPRO
ABSTRACT
Immunoadsorption can selectively remove pathogenic antibodies and has recently achieved good results in neuroimmune diseases. The type and titer of pathogenic antibodies play an important role in the clinical symptoms and severity of patients with autoimmune encephalitis. First-line immunotherapy for autoimmune encephalitis includes steroids, intravenous immunoglobulin, plasma exchange or immunoadsorption. Immunoadsorption selectively and rapidly eliminates autoantibodies and can be an effective therapeutic option as part of multimodal immunotherapy.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Neurology
Ano de publicação:
2022
Tipo de documento:
Article